Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Elmwood Park › NPI 1134277494
Lab

Bioreference Health, LLC

Bioreference Health, LLC was paid $620.07M by Medicaid between Jan 2018 and Dec 2024, across 626 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 7.7% of everything it billed.

33Billing provider infoBIOREFERENCE HEALTH, LLC
ELMWOOD PARK, NJ 07407
33aNPI1134277494assigned 01/05/2007
33bProvider typeClinical Medical Laboratory
28Total paid$620.07M
24GClaims60,790,152
24DCodes billed626
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#3 of 122
Median peer was paid$1.29M
This provider vs. median482×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0M$10M$15M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,347,887$77.58M
20198,196,547$80.24M
20208,499,441$101.71M
202110,423,125$116.73M
20229,888,209$97.44M
20239,355,723$85.25M
2024incomplete7,079,220$61.11M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.7% 675,267 589,139 $48.01M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.4% 1,871,552 1,817,958 $33.54M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5.3% 1,930,171 1,804,750 $32.87M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.9% 1,451,734 1,437,824 $24.37M
80053 Comprehensive metabolic panel 2.5% 2,774,574 2,692,157 $15.67M
86769 2.4% 414,944 382,851 $14.83M
80050 General health panel 2.3% 766,636 762,568 $14.50M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 2.3% 406,842 383,219 $14.29M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.2% 1,160,901 1,142,928 $13.88M
86480 2.2% 400,056 398,382 $13.50M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2.0% 726,165 701,731 $12.12M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.9% 735,611 718,076 $11.92M
614 more codes
80061 Lipid panel 1.9% 2,715,230 $11.76M
83036 Hemoglobin; glycosylated (A1C) 1.8% 2,315,069 $11.40M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.7% 596,613 $10.46M
84443 Thyroid stimulating hormone (TSH) 1.6% 1,657,860 $9.97M
87799 1.4% 227,895 $8.61M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 552,278 $7.95M
86481 1.3% 223,796 $7.94M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 3,079,186 $7.78M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1.2% 44,186 $7.62M
82607 1.1% 883,898 $6.91M
88305 Level IV - Surgical pathology, gross and microscopic examination 1.1% 141,546 $6.67M
87536 1.1% 96,771 $6.61M
81507 <1% 23,308 $6.17M
86803 <1% 901,263 $6.07M
87512 <1% 260,266 $5.74M
87340 <1% 957,707 $5.73M
87481 <1% 246,776 $5.73M
86003 <1% 96,012 $5.12M
82746 <1% 708,219 $5.05M
87563 <1% 287,078 $4.82M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 321,659 $4.73M
86706 <1% 775,902 $4.44M
84439 <1% 846,775 $4.26M
81001 <1% 2,054,771 $4.12M
87086 Culture, bacterial; quantitative colony count, urine <1% 854,317 $3.90M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 13,582 $3.83M
88185 <1% 19,402 $3.80M
82728 <1% 519,793 $3.67M
82107 <1% 101,032 $3.58M
83655 <1% 425,005 $3.46M
87529 <1% 93,313 $3.39M
84403 <1% 190,350 $3.21M
86360 <1% 82,411 $3.10M
84153 <1% 282,860 $3.00M
86762 <1% 343,107 $2.99M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 33,727 $2.92M
86704 <1% 478,052 $2.92M
87077 <1% 462,643 $2.91M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 171,004 $2.90M
87517 <1% 101,386 $2.66M
82670 <1% 145,710 $2.60M
86592 <1% 1,154,798 $2.52M
86708 <1% 390,215 $2.46M
86765 <1% 303,468 $2.46M
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 10,196 $2.40M
83540 <1% 789,292 $2.17M
86696 <1% 221,912 $2.15M
87088 <1% 336,466 $2.05M
84702 <1% 271,546 $2.04M
87660 <1% 206,695 $1.98M
87510 <1% 199,585 $1.94M
87480 <1% 194,011 $1.90M
84146 <1% 151,765 $1.88M
80081 <1% 51,371 $1.87M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 61,020 $1.86M
87070 <1% 366,948 $1.85M
84270 <1% 147,841 $1.82M
83001 <1% 161,290 $1.82M
86235 <1% 84,165 $1.81M
83021 <1% 157,012 $1.74M
84550 <1% 681,866 $1.74M
86709 <1% 283,864 $1.74M
87186 <1% 354,372 $1.74M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 43,624 $1.71M
82043 <1% 602,422 $1.69M
88313 <1% 30,839 $1.69M
86787 <1% 297,017 $1.69M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 100,444 $1.65M
83550 <1% 520,217 $1.64M
84154 <1% 138,478 $1.62M
83002 <1% 142,445 $1.59M
86735 <1% 280,138 $1.57M
82570 <1% 575,221 $1.54M
86355 <1% 82,491 $1.51M
84144 <1% 119,762 $1.50M
86359 <1% 82,386 $1.49M
86357 <1% 80,483 $1.47M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 60,236 $1.45M
83013 <1% 42,999 $1.45M
82977 <1% 462,966 $1.45M
87522 Neg quan hep c or qual rna <1% 49,906 $1.44M
86780 <1% 175,682 $1.44M
87902 <1% 7,917 $1.33M
88344 <1% 23,760 $1.32M
86695 <1% 174,954 $1.31M
87631 <1% 18,032 $1.30M
88341 <1% 28,930 $1.26M
83615 <1% 404,000 $1.21M
86376 <1% 142,981 $1.21M
82652 <1% 72,540 $1.17M
88374 <1% 9,844 $1.15M
88141 <1% 111,523 $1.10M
81539 <1% 7,959 $1.09M
84481 <1% 164,274 $1.07M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 7,481 $1.07M
84480 <1% 230,247 $1.03M
88342 <1% 45,789 $1.03M
83970 <1% 47,704 $990K
82627 <1% 70,070 $946K
84100 <1% 343,357 $929K
36415 Collection of venous blood by venipuncture <1% 1,787,774 $927K
82785 <1% 106,348 $884K
84207 <1% 46,834 $840K
81329 <1% 20,992 $814K
80048 Basic metabolic panel (calcium, ionized) <1% 195,067 $804K
86038 <1% 186,032 $764K
86141 <1% 114,581 $746K
87634 <1% 37,165 $735K
87350 <1% 123,243 $716K
88121 <1% 7,209 $713K
84436 <1% 222,215 $712K
87653 <1% 47,483 $711K
86707 <1% 118,494 $699K
81443 <1% 2,225 $699K
88142 <1% 52,177 $660K
82274 <1% 183,608 $657K
82248 <1% 236,534 $646K
80074 <1% 28,515 $625K
86800 <1% 71,039 $577K
87901 <1% 3,345 $573K
80055 <1% 27,497 $560K
86618 <1% 45,363 $545K
88112 <1% 29,806 $527K
84425 <1% 50,538 $494K
82378 <1% 52,932 $491K
86140 <1% 191,517 $479K
81243 <1% 21,811 $478K
86147 <1% 20,640 $478K
86617 <1% 28,858 $468K
81511 <1% 21,390 $464K
84252 <1% 37,430 $435K
86431 <1% 141,917 $433K
84445 <1% 15,697 $424K
85651 <1% 294,435 $423K
88189 <1% 16,523 $414K
86200 <1% 55,790 $414K
83516 <1% 52,232 $412K
88184 <1% 21,546 $407K
86665 <1% 21,863 $391K
86225 <1% 90,635 $390K
83735 <1% 132,136 $381K
82784 <1% 36,227 $365K
85027 <1% 157,696 $362K
86677 <1% 36,226 $359K
87501 <1% 8,781 $357K
83525 <1% 52,613 $354K
83090 <1% 33,513 $349K
85610 <1% 163,104 $347K
82465 <1% 144,426 $345K
82668 <1% 39,851 $343K
84460 <1% 141,128 $343K
86850 <1% 101,332 $337K
80076 <1% 81,291 $337K
86334 <1% 32,432 $335K
82950 <1% 116,608 $325K
81450 <1% 4,846 $321K
82626 <1% 21,345 $317K
86146 <1% 13,900 $312K
85730 <1% 110,341 $311K
84479 <1% 127,166 $310K
81422 <1% 4,998 $307K
86901 <1% 171,973 $307K
84446 <1% 33,404 $305K
82105 <1% 52,959 $302K
86900 <1% 172,240 $302K
83498 <1% 17,870 $298K
83701 <1% 25,527 $298K
86160 <1% 29,076 $294K
87486 <1% 17,299 $272K
81401 <1% 4,038 $271K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 59,300 $271K
88262 <1% 5,281 $269K
84590 <1% 35,488 $264K
82040 <1% 154,388 $264K
86300 <1% 25,847 $263K
87338 <1% 45,046 $258K
87581 <1% 17,305 $258K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 27,275 $257K
86705 <1% 42,316 $251K
86039 <1% 64,333 $251K
84450 <1% 146,818 $241K
82550 <1% 80,379 $239K
84075 <1% 107,474 $236K
86304 <1% 24,951 $236K
83690 <1% 66,632 $235K
87177 <1% 34,411 $234K
87209 <1% 37,495 $234K
82533 <1% 22,976 $217K
83695 <1% 28,259 $202K
88365 <1% 3,371 $201K
88304 <1% 11,851 $200K
88108 <1% 13,987 $199K
81206 <1% 4,195 $198K
85045 <1% 101,930 $197K
83880 <1% 12,475 $197K
86008 <1% 24,616 $194K
83883 <1% 28,730 $192K
82947 <1% 109,422 $190K
82172 <1% 17,761 $188K
87640 <1% 12,186 $185K
82150 <1% 63,624 $184K
88377 <1% 1,477 $180K
83010 <1% 26,034 $179K
82951 <1% 31,458 $177K
87906 <1% 1,962 $176K
88237 <1% 3,726 $176K
84432 <1% 20,252 $175K
84255 <1% 11,384 $175K
81207 <1% 4,160 $169K
84165 <1% 38,406 $167K
86777 <1% 19,473 $167K
82247 <1% 127,923 $167K
84478 <1% 60,336 $165K
80051 <1% 43,003 $164K
86301 <1% 18,488 $163K
87900 <1% 2,687 $159K
87807 <1% 19,355 $159K
86644 <1% 17,894 $158K
86256 <1% 15,404 $156K
88307 <1% 1,202 $155K
86060 <1% 42,591 $149K
84681 <1% 12,236 $148K
86258 <1% 9,458 $147K
84305 <1% 11,907 $145K
82310 <1% 62,663 $144K
87046 <1% 24,764 $144K
83521 <1% 10,919 $141K
83520 <1% 17,076 $138K
83921 <1% 13,587 $134K
82575 <1% 34,713 $134K
86664 <1% 15,034 $133K
87045 <1% 24,790 $132K
86255 <1% 25,119 $130K
86593 <1% 52,408 $129K
81596 <1% 4,345 $128K
87109 <1% 15,987 $126K
84378 <1% 17,223 $125K
87075 <1% 22,117 $124K
84156 <1% 60,842 $117K
86335 <1% 8,394 $115K
81241 <1% 6,155 $114K
86663 <1% 14,990 $114K
82679 <1% 7,818 $114K
81270 <1% 3,893 $112K
85613 <1% 10,989 $110K
82397 <1% 18,133 $109K
84155 <1% 124,719 $108K
82380 <1% 17,903 $103K
85598 <1% 9,943 $101K
87400 <1% 9,589 $101K
88367 <1% 3,408 $100K
80069 <1% 23,867 $100K
85660 <1% 34,537 $100K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,251 $100K
85060 <1% 9,019 $99K
86645 <1% 15,661 $98K
81402 <1% 1,833 $98K
86778 <1% 12,191 $96K
82157 <1% 5,919 $95K
86747 <1% 6,482 $95K
80164 <1% 12,653 $94K
81400 <1% 2,550 $94K
88360 <1% 3,073 $94K
86036 <1% 5,179 $92K
81240 <1% 5,131 $90K
82024 <1% 4,325 $90K
83825 <1% 9,040 $89K
86364 <1% 5,959 $89K
82166 <1% 5,715 $88K
86021 <1% 10,429 $85K
88230 <1% 2,485 $85K
86774 <1% 9,473 $85K
81219 <1% 2,249 $85K
82088 <1% 3,511 $84K
82677 <1% 7,171 $81K
88381 <1% 2,391 $81K
82565 <1% 33,703 $81K
84520 <1% 71,633 $81K
85018 <1% 70,361 $80K
82671 <1% 4,347 $80K
84166 <1% 9,544 $79K
88373 <1% 3,381 $79K
84466 <1% 12,222 $78K
81256 <1% 1,608 $77K
85306 <1% 6,648 $77K
86231 <1% 9,240 $77K
84630 <1% 14,431 $76K
86870 <1% 5,591 $75K
87184 <1% 15,850 $74K
81508 <1% 7,313 $73K
81403 <1% 1,170 $72K
86812 <1% 5,645 $69K
86753 <1% 5,398 $69K
86381 <1% 5,554 $69K
85097 <1% 3,375 $68K
85240 <1% 8,801 $67K
85014 <1% 57,588 $66K
80177 <1% 9,530 $66K
86666 <1% 5,175 $64K
86757 <1% 2,540 $61K
81279 <1% 1,425 $58K
87205 <1% 26,567 $58K
85597 <1% 6,847 $58K
85379 <1% 11,826 $58K
87324 <1% 10,188 $58K
85246 <1% 5,413 $57K
81445 <1% 712 $57K
82985 <1% 8,997 $55K
88361 <1% 572 $54K
81338 <1% 1,516 $53K
82232 <1% 7,948 $52K
82552 <1% 3,480 $49K
87493 <1% 2,570 $49K
86317 <1% 2,256 $48K
88187 <1% 2,846 $47K
86702 <1% 6,042 $47K
86631 <1% 3,939 $46K
83014 <1% 14,394 $45K
81257 <1% 1,278 $44K
82180 <1% 7,432 $42K
84402 <1% 2,893 $42K
85303 <1% 6,024 $42K
82952 <1% 27,159 $41K
87341 <1% 7,972 $41K
86148 <1% 5,348 $41K
84482 <1% 7,053 $40K
83993 <1% 5,420 $40K
86015 <1% 5,004 $40K
86738 <1% 3,178 $40K
87449 <1% 10,468 $39K
82108 <1% 2,293 $38K
85245 <1% 4,396 $38K
87329 <1% 5,227 $37K
81513 <1% 815 $37K
82731 <1% 1,052 $37K
83018 <1% 2,957 $37K
82525 <1% 5,089 $37K
83718 <1% 11,386 $36K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 4,650 $36K
86701 <1% 6,162 $36K
82610 <1% 2,694 $35K
86615 <1% 3,436 $35K
86382 <1% 3,744 $35K
81382 <1% 741 $35K
82390 <1% 7,200 $35K
80178 <1% 8,161 $35K
86671 <1% 2,984 $34K
85250 <1% 3,655 $34K
85300 <1% 5,823 $33K
81374 <1% 707 $33K
88323 <1% 912 $33K
85307 <1% 2,854 $33K
85384 <1% 8,011 $32K
85270 <1% 3,592 $32K
83020 <1% 4,217 $32K
84202 <1% 5,020 $31K
82542 <1% 2,977 $31K
86632 <1% 4,121 $31K
83003 <1% 2,749 $31K
82272 <1% 16,671 $30K
81205 <1% 1,347 $30K
86790 <1% 2,869 $30K
80415 <1% 804 $29K
81025 <1% 12,641 $28K
86340 <1% 4,734 $28K
87625 <1% 1,562 $26K
86638 <1% 1,311 $25K
83630 <1% 4,791 $25K
84244 <1% 1,976 $25K
82164 <1% 3,125 $25K
83721 <1% 4,848 $25K
82140 <1% 3,116 $24K
88173 <1% 752 $24K
83789 <1% 2,255 $24K
87535 <1% 1,813 $24K
81291 <1% 1,327 $23K
81255 <1% 1,295 $23K
85280 <1% 2,463 $23K
86611 <1% 2,603 $23K
82103 <1% 3,570 $22K
82330 <1% 5,964 $22K
88291 <1% 2,781 $22K
81251 <1% 1,357 $22K
82239 <1% 2,684 $22K
83519 <1% 2,657 $22K
88312 <1% 983 $22K
81381 <1% 305 $22K
82747 <1% 2,750 $21K
80159 <1% 2,172 $21K
86308 <1% 7,249 $21K
81050 <1% 13,055 $21K
81503 <1% 188 $20K
81330 <1% 1,282 $20K
87496 <1% 1,144 $20K
83698 <1% 1,330 $20K
82955 <1% 2,954 $19K
82787 <1% 1,493 $19K
86692 <1% 2,018 $19K
81250 <1% 1,351 $18K
84132 <1% 8,027 $18K
81229 <1% 1,031 $18K
86658 <1% 471 $18K
81342 <1% 291 $18K
86001 <1% 5,903 $17K
81509 <1% 82 $17K
81479 Unlisted molecular pathology procedure <1% 434 $17K
87116 <1% 2,697 $17K
88311 <1% 3,278 $17K
81200 <1% 1,287 $17K
87497 <1% 1,907 $17K
87662 <1% 547 $17K
86886 <1% 5,460 $16K
86162 <1% 1,516 $16K
85305 <1% 2,591 $16K
83835 <1% 1,537 $15K
87912 <1% 133 $15K
81209 <1% 1,291 $15K
81260 <1% 1,286 $15K
86215 <1% 3,199 $15K
81242 <1% 1,354 $15K
86005 <1% 3,180 $15K
80197 <1% 3,146 $15K
81458 <1% 70 $15K
81235 <1% 226 $15K
87328 <1% 1,737 $14K
87040 <1% 2,799 $14K
87207 <1% 2,543 $14K
82175 <1% 1,218 $14K
86305 <1% 1,225 $14K
84238 <1% 1,237 $14K
85049 <1% 6,922 $14K
81276 <1% 362 $14K
84134 <1% 2,494 $14K
81275 <1% 391 $13K
82530 <1% 1,445 $13K
81210 <1% 311 $13K
82681 <1% 824 $13K
85247 <1% 1,455 $13K
81290 <1% 1,288 $13K
85302 <1% 2,070 $12K
99199 Unlisted special service, procedure or report <1% 2,653 $12K
82553 <1% 2,486 $12K
80156 <1% 1,555 $12K
82085 <1% 2,017 $12K
84260 <1% 880 $12K
84140 <1% 949 $11K
86341 <1% 1,023 $11K
87206 <1% 3,837 $11K
87102 <1% 2,004 $11K
87252 <1% 607 $10K
86880 <1% 4,361 $10K
86316 <1% 1,499 $10K
81311 <1% 165 $9K
81162 <1% 27 $9K
84560 <1% 3,180 $9K
80175 <1% 1,502 $9K
81176 <1% 215 $9K
84484 <1% 1,735 $9K
86682 <1% 1,168 $9K
87015 <1% 4,235 $8K
87101 <1% 1,746 $8K
84703 <1% 3,797 $8K
85420 <1% 2,654 $8K
85652 <1% 6,984 $8K
81376 <1% 405 $8K
80185 <1% 1,174 $8K
84300 <1% 3,218 $8K
84163 <1% 878 $7K
85670 <1% 2,786 $7K
82365 <1% 1,051 $7K
82941 <1% 636 $7K
86606 <1% 620 $7K
83527 <1% 944 $7K
81405 <1% 422 $7K
86337 <1% 884 $7K
83700 <1% 1,315 $7K
84540 <1% 2,170 $6K
83625 <1% 1,128 $6K
86622 <1% 825 $6K
82384 <1% 539 $6K
81170 <1% 74 $6K
87107 <1% 898 $6K
80183 <1% 912 $6K
82340 <1% 1,901 $6K
80203 <1% 762 $6K
88104 <1% 393 $6K
88300 <1% 525 $5K
84080 <1% 864 $5K
88364 <1% 138 $5K
87081 <1% 1,372 $5K
87220 <1% 1,730 $5K
82656 <1% 1,145 $5K
82300 <1% 421 $4K
85007 <1% 5,636 $4K
83874 <1% 665 $4K
83992 <1% 510 $4K
84295 <1% 2,639 $4K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 552 $4K
87538 <1% 248 $4K
83935 <1% 1,276 $4K
80348 <1% 362 $4K
81404 <1% 273 $4K
88235 <1% 56 $4K
81432 <1% 31 $4K
87168 <1% 631 $4K
84133 <1% 1,598 $4K
80184 <1% 397 $3K
82308 <1% 211 $3K
86849 <1% 388 $3K
88271 <1% 55 $3K
82705 <1% 1,101 $3K
85301 <1% 565 $3K
84442 <1% 491 $3K
0099U <1% 1,002 $3K
86609 <1% 416 $3K
82139 <1% 310 $3K
80165 <1% 430 $3K
80349 <1% 627 $3K
80353 <1% 562 $3K
82077 <1% 200 $3K
80361 <1% 564 $2K
82436 <1% 1,017 $2K
86710 <1% 75 $2K
80346 <1% 520 $2K
87332 <1% 300 $2K
80320 <1% 403 $2K
83930 <1% 788 $2K
86635 <1% 245 $2K
80162 <1% 497 $2K
82608 <1% 252 $2K
87106 <1% 293 $2K
86352 <1% 27 $2K
80324 <1% 419 $2K
87337 <1% 354 $2K
85048 <1% 1,233 $2K
85611 <1% 435 $2K
88188 <1% 102 $2K
82435 <1% 2,096 $1K
85008 <1% 735 $1K
82523 <1% 186 $1K
G0141 Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician <1% 223 $1K
88275 <1% 54 $1K
82945 <1% 287 $1K
82374 <1% 1,360 $1K
84597 <1% 149 $1K
85732 <1% 520 $1K
80354 <1% 46 $1K
82104 <1% 158 $1K
86689 <1% 130 $1K
80365 <1% 831 $1K
80358 <1% 298 $1K
81406 <1% 216 $1K
81321 <1% 18 $1K
81301 <1% 27 $996.96
80202 <1% 126 $978.13
86336 <1% 167 $964.61
87511 <1% 30 $925.31
83605 <1% 167 $912.18
80321 <1% 80 $873.00
83945 <1% 124 $872.35
89060 <1% 256 $852.75
81245 <1% 12 $849.99
84376 <1% 286 $842.21
88274 <1% 41 $811.43
80345 <1% 201 $803.82
86022 <1% 115 $765.38
88182 <1% 14 $735.54
87110 <1% 106 $733.39
85290 <1% 111 $726.98
80047 <1% 152 $711.51
89051 <1% 267 $686.62
84591 <1% 128 $655.23
87425 <1% 81 $634.38
83088 <1% 40 $598.79
87471 <1% 28 $580.92
89320 <1% 592 $578.62
82540 <1% 264 $512.13
81412 <1% 12 $511.78
84311 <1% 300 $499.09
87172 <1% 369 $495.37
84066 <1% 80 $468.50
84105 <1% 140 $373.05
80359 <1% 61 $364.55
87140 <1% 105 $344.53
84145 <1% 30 $344.51
82725 <1% 57 $294.52
80367 <1% 72 $286.40
80323 <1% 83 $284.70
80350 <1% 76 $282.42
81246 <1% 41 $277.18
81228 <1% 16 $249.60
82595 <1% 72 $205.08
80356 <1% 56 $200.28
82507 <1% 12 $190.36
87533 <1% 16 $167.72
85260 <1% 14 $161.30
80186 <1% 24 $125.99
82375 <1% 13 $90.31
80201 <1% 14 $81.84
85130 <1% 13 $79.30
80362 <1% 13 $75.00
86905 <1% 34 $64.14
80157 <1% 12 $61.48
86023 <1% 13 $51.69
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 409 $33.12
99999 0% 329 $0.00
81407 0% 114 $0.00
99213 Doctor's office visit, returning patient (routine) 0% 102 $0.00
ATP17 0% 28 $0.00
81244 0% 24 $0.00
99080 0% 13,216 $0.00
81408 0% 134 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 28 $0.00
ATP18 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHMID, MICHAEL (SVP, CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under SCHMID, MICHAEL

Full network →
ProviderLocationPaid
Bioreference Health, LLCHouston, TX$8.87M
Florida Clinical Laboratory, INCMelbourne, FL$549K
Bioreference Health, LLCMineola, NY$175K
Bioreference Health, LLCHouston, TX$117K
Bioreference Health, LLCBurbank, CA$25K
Bioreference Health, LLCGaithersburg, MD$8K
Bioreference Health, LLCHackensack, NJ$22.86

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.